-
A common cholesterol drug may weaken ovarian cancer's hidden shield
Ascites—the buildup of liquid in the belly—may be doing more than causing discomfort. A Duke University School of Medicine study... Read more -
Depression may be overdiagnosed in patients with ovarian cancer
People with ovarian cancer could be being overdiagnosed with depression due to the physical symptoms they experience as part of... Read more -
Slow-dividing breast cancer cells may explain relapses decades after treatment
A new study by the Garvan Institute of Medical Research has uncovered a hidden mechanism explaining why breast cancer can... Read more -
Public education key in new cervical cancer screening
As Canada moves to modernize cervical cancer screening, a new study suggests most women do not yet understand or trust... Read more -
Urine test outperforms MRI for monitoring low-risk prostate cancer in new study
A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active surveillance. Use... Read more -
Immunologist's lab demonstrates the power of B cells to gather and defend organs against cancer
Creativity and curiosity have always been central to the work of Joshua Moreau, Ph.D., an immunologist whose work at Oregon... Read more -
IL-10 gene therapy boosts immune attack against liver cancer in mice
Researchers at National Taiwan University have developed a liver-directed IL-10 gene therapy that strengthens cancer-fighting immune cells and suppresses liver... Read more -
Cancer cells are better able to resist treatments when they have an abnormal number of chromosomes
A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments... Read more -
National study examines genetic testing to inform follow-up care for cancer survivors
Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing... Read more -
Lung cancer screening rates up, yet remain low
A new University of Kentucky Markey Cancer Center study published in JAMA Internal Medicine found that lung cancer screening rates... Read more -
Combination therapy with stem cell-derived immune cells boosts anti-cancer response
Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if... Read more -
Solving a 15-year mystery: Scientists discover how gut bacteria toxin invades colon cells to trigger cancer
Since a landmark 2009 study, researchers have known that a common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially... Read more -
New ultrasonic needle yields samples 2–3 times larger, potentially reshaping cancer diagnostics
Developed at Aalto University over several years, a new ultrasonic needle for tumor diagnostics has been trialed in collaboration with... Read more -
RAS(ON) inhibitor daraxonrasib shows promising results in advanced pancreatic cancer
The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated... Read more -
Study identifies new strategy to overcome immunotherapy resistance in colorectal cancer
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a... Read more
